Sydney-based Pharmaxis (ASX:PXS) has announced the first patient has been dosed in its Phase 1 clinical trial of an anti‐fibrotic Lysyl Oxidase (LOX) inhibitor focused on treating pancreatic cancer.
-
Latest News Pharmaxis doses first patient in LOX inhibitor trial February 26, 2019
-
Imagion Biosystems updates on development milestone February 26, 2019Imagion Biosystems (ASX:IBX) says it has achieved a key milestone in its progress to first-in-human testing with the commencement of a toxicology safety study of its lead nanoparticle formulation for the detection of HER2 metastatic breast cancer.
-
Latest News Rhythm announces first study site for trial of new colorectal cancer diagnostic February 21, 2019Rhythm Biosciences (ASX:RHY) has announced that Adelaide’s Lyell McEwin Hospital will be the first study site for the 1,000-patient prospective clinical trial of its blood test, ColoSTAT, for the early detection of colorectal cancer.
-
AusBiotech Boosting Australia at BioKorea 2019 February 21, 2019AusBiotech will be amongst the action, boosting Australia’s connections and reputation at BioKorea by supporting the Australian pavilion and conference sessions taking place.
-
Latest News Melbourne-based company updates on pain trial February 21, 2019Melbourne-based company Medical Ethics has announced the first patient has been successfully treated in its Phase 2a study of Tri-Solfen and Medi-Solfen.
-
Latest News First equity raise for hearing solutions company Hemideina February 20, 2019Hemideina, a hearing solutions company focussed on the development and commercialisation of the Hera Wireless Implant, has successfully raised a Series A investment of $1 million in their first round of equity financing.
-
Latest News Fate of R&D tax reform a matter for election winner February 20, 2019The fate of the federal government's proposed reforms to cut spending on the R&D Tax Incentive is unlikely to be resolved before the election.
New Stories
-
Trial results give hope on peanut allergy
February 26, 2019 - - Latest News -
Pharmaxis doses first patient in LOX inhibitor trial
February 26, 2019 - - Latest News -
Imagion Biosystems updates on development milestone
February 26, 2019 - -
Government announces new '10-year Mission for Cardiovascular Health'
February 26, 2019 - - Latest News -
Keynote speakers announced: Kate Carnell and Karen Bevan
February 26, 2019 - - AusBiotech -
Rhythm announces first study site for trial of new colorectal cancer diagnostic
February 21, 2019 - - Latest News -
Melbourne-based company updates on pain trial
February 21, 2019 - - Latest News